Study in Patients With Asthma
Completed · Phase 2
Conditions studied: Asthma
In brief
The purpose of this study is to determine the most safe and effective dose of the investigational drug in comparison with a control drug and placebo.
Key facts
- Study ID
- NCT00215410
- Run by
- Dey
- People needed
- 36
- Expected to finish
- 2005-10-01
- Last updated by the study team
- 2010-11-11
Who can join
Age: 5 and older, up to 12. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Children with a history of asthma
- Written guardian approval
You may not qualify if…
- Current or recent asthma exacerbation, requiring hospitalization
- History of smoking
- Debilitating or systemic and/or life-threatening diseases.
Where it is running
- Research Site — Little Rock, Arkansas, United States
- Research Site — Long Beach, California, United States
- Research Site — Mission Viejo, California, United States
- Research Site — Newport Beach, California, United States
- Research Site — Orange, California, United States
- Research Site — Vista, California, United States
- Research Site — Englewood, Colorado, United States
- Research Site — Oklahoma City, Oklahoma, United States
- Research Site — Medford, Oregon, United States
- Research Site — Portland, Oregon, United States
- Research Site — Fort Worth, Texas, United States
- Research Site — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.